{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:40:26Z","timestamp":1767145226387,"version":"build-2238731810"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["H2019032"],"award-info":[{"award-number":["H2019032"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670965"],"award-info":[{"award-number":["81670965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970961"],"award-info":[{"award-number":["81970961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20191346"],"award-info":[{"award-number":["BK20191346"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bone.2023.116677","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T06:02:25Z","timestamp":1673589745000},"page":"116677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bone-targeted bortezomib increases bone formation within Calvarial trans-sutural distraction osteogenesis"],"prefix":"10.1016","volume":"169","author":[{"given":"Hongyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanhui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaolan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F","article-title":"Cranial sutures as intramembranous bone growth sites","volume":"219","author":"Opperman","year":"2000","journal-title":"Dev. Dynam."},{"key":"10.1016\/j.bone.2023.116677_bb0010","article-title":"Spatial distributions, characteristics, and applications of craniofacial stem cells","volume":"1\u20139","author":"Zhang","year":"2020","journal-title":"Stem Cells Int."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0015","doi-asserted-by":"crossref","first-page":"170e","DOI":"10.1097\/01.prs.0000304441.99483.97","article-title":"Cranial sutures: a brief review","volume":"121","author":"Slater","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajhg.2015.07.006","article-title":"A genetic-pathophysiological framework for craniosynostosis","volume":"97","author":"Twigg","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"5B","key":"10.1016\/j.bone.2023.116677_bb0025","first-page":"13","article-title":"Craniosynostosis and syndromes with craniosynostosis: incidence, genetics, penetrance, variability, and new syndrome updating","volume":"15","author":"Cohen","year":"1979","journal-title":"Birth Defects Orig. Artic. Ser."},{"issue":"7","key":"10.1016\/j.bone.2023.116677_bb0030","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ajmg.a.35367","article-title":"Saethre-chotzen phenotype with learning disability and hyper IgE phenotype in a patient due to complex chromosomal rearrangement involving chromosomes 3 and 7","volume":"158a","author":"Zechi-Ceide","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0035","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1542\/peds.2014-1634","article-title":"Intellectual and academic functioning of school-age children with single-suture craniosynostosis","volume":"135","author":"Speltz","year":"2015","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1369\/0022155418793588","article-title":"Expression of non-collagenous bone matrix proteins in osteoblasts stimulated by mechanical stretching in the cranial suture of neonatal mice","volume":"67","author":"Ikegame","year":"2019","journal-title":"J. Histochem. Cytochem."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/PRS.0000000000001375","article-title":"Trans-sutural distraction osteogenesis for midfacial hypoplasia in growing patients with cleft lip and palate: clinical outcomes and analysis of skeletal changes","volume":"136","author":"Tong","year":"2015","journal-title":"Plast. Reconstr. Surg."},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/oxfordjournals.ejo.a035971","article-title":"Stability of magnetic versus mechanical palatal expansion","volume":"11","author":"Vardimon","year":"1989","journal-title":"Eur. J. Orthod."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jbiomech.2014.12.032","article-title":"Biglycan mediates suture expansion osteogenesis via potentiation of Wnt\/beta-catenin signaling","volume":"48","author":"Wang","year":"2015","journal-title":"J. Biomech."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0060","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00056-011-0034-3","article-title":"Effect of vitamin C on bone formation in the expanded inter-premaxillary suture Early bone changes","volume":"72","author":"Uysal","year":"2011","journal-title":"J. Orofac. Orthop."},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ajodo.2013.03.017","article-title":"Recombinant human bone morphogenetic protein-2 stimulates bone formation during interfrontal suture expansion in rabbits","volume":"144","author":"Liu","year":"2013","journal-title":"Am. J. Orthod. Dentofac. Orthop."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2319\/031114-177.1","article-title":"Bone marrow mesenchymal stem cells enhance bone formation in orthodontically expanded maxillae in rats","volume":"85","author":"Ekizer","year":"2015","journal-title":"Angle Orthod"},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI71602","article-title":"Emerging therapies targeting the ubiquitin proteasome system in cancer","volume":"124","author":"Weathington","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.seminhematol.2012.04.011","article-title":"Proteasome inhibitors and bone disease","volume":"49","author":"Qiang","year":"2012","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0085","first-page":"491","article-title":"Pharmacologic targeting of a stem\/progenitor population in vivo is associated with enhanced bone regeneration in mice","volume":"118","author":"Mukherjee","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.bone.2023.116677_bb0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3816\/CLM.2007.n.045","article-title":"Bortezomib inhibits osteoclast activity in patients with multiple myeloma","volume":"7","author":"Uy","year":"2007","journal-title":"Clin. Lymphoma Myeloma"},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0095","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood-2006-11-059188","article-title":"The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients","volume":"110","author":"Giuliani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bone.2023.116677_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.294","article-title":"Withaferin a: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone","volume":"4","author":"Khedgikar","year":"2013","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0105","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.cdd.4402297","article-title":"Proteasome inhibition drastically but reversibly impairs murine lymphocyte development","volume":"15","author":"Maseda","year":"2008","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.bone.2023.116677_bb0110","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1172\/JCI75247","article-title":"Proteasome function is required for platelet production","volume":"124","author":"Shi","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/ejh.12342","article-title":"Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes","volume":"93","author":"Murai","year":"2014","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0120","first-page":"115","article-title":"Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice","volume":"29","author":"Meregalli","year":"2015","journal-title":"J. Biol. Reg. Homeos. Ag."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0125","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.expneurol.2006.11.010","article-title":"Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat","volume":"204","author":"Cavaletti","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bone.2023.116677_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119885","article-title":"Dopamine-modified poly(\u03b5-caprolactone) micelles for pH controlled delivery of bortezomib","volume":"590","author":"Liu","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","article-title":"The relationship between the chemistry and biological activity of the bisphosphonates","volume":"49","author":"Ebetino","year":"2011","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2023.116677_bb0140","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/bph.15251","article-title":"Bisphosphonates for delivering drugs to bone","volume":"178","author":"Sun","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2006.11.024","article-title":"Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro","volume":"331","author":"Hengst","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.bone.2023.116677_bb0150","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1016\/j.bmcl.2013.09.043","article-title":"Design, synthesis, and biological evaluation of bone-targeted proteasome inhibitors for multiple myeloma","volume":"23","author":"Agyin","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0155","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jbmr.2382","article-title":"Novel EP4 receptor agonist-bisphosphonate conjugate drug (C1) promotes bone formation and improves vertebral mechanical properties in the ovariectomized rat model of postmenopausal bone loss","volume":"30","author":"Liu","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030154","article-title":"Synthesis of a bone-targeted bortezomib with in vivo anti-myeloma effects in mice","volume":"10","author":"Wang","year":"2018","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bone.2023.116677_bb0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jbmr.3889","article-title":"Targeting bortezomib to bone increases its bone anabolic activity and reduces systemic adverse effects in mice","volume":"35","author":"Wang","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jbmr.4496","article-title":"Bone-targeted bortezomib inhibits bortezomib-resistant multiple myeloma in mice by providing higher levels of bortezomib in bone","volume":"37","author":"Tao","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2023.116677_bb0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1902\/jop.2016.160396","article-title":"The proteasome inhibitor bortezomib inhibits inflammatory response of periodontal ligament cells and ameliorates experimental periodontitis in rats","volume":"88","author":"Jiang","year":"2017","journal-title":"J. Periodontol."},{"issue":"9","key":"10.1016\/j.bone.2023.116677_bb0180","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1359\/jbmr.2003.18.9.1706","article-title":"Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo","volume":"18","author":"Morinobu","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00774-016-0737-z","article-title":"In vivo expression and regulation of genes associated with vascularization during early response of sutures to tensile force","volume":"35","author":"Takeshita","year":"2017","journal-title":"J. Bone Miner. Metab."},{"issue":"9","key":"10.1016\/j.bone.2023.116677_bb0190","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1002\/jcp.29522","article-title":"ROCK-TAZ signaling axis regulates mechanical tension-induced osteogenic differentiation of rat cranial sagittal suture mesenchymal stem cells","volume":"235","author":"Li","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PRS.0b013e31817747b5","article-title":"Proliferation, osteogenic differentiation, and fgf-2 modulation of posterofrontal\/sagittal suture-derived mesenchymal cells in vitro","volume":"122","author":"James","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0200","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.prs.0000255540.91987.a0","article-title":"Isolation and characterization of posterofrontal\/sagittal suture mesenchymal cells in vitro","volume":"119","author":"Xu","year":"2007","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0205","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.090812","article-title":"Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice","volume":"25","author":"Zhang","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2023.116677_bb0210","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/stem.1395","article-title":"Ubiquitin e3 ligase itch negatively regulates osteoblast differentiation from mesenchymal progenitor cells","volume":"31","author":"Zhang","year":"2013","journal-title":"Stem Cells"},{"issue":"15","key":"10.1016\/j.bone.2023.116677_bb0215","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1074\/jbc.M706415200","article-title":"Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism","volume":"283","author":"Yao","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bone.2023.116677_bb0220","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.joms.2014.07.004","article-title":"Bisphosphonate uptake in areas of tooth extraction or periapical disease","volume":"72","author":"Cheong","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0225","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.stemcr.2017.03.002","article-title":"Postnatal calvarial skeletal stem cells expressing PRX1 reside exclusively in the calvarial sutures and are required for bone regeneration","volume":"8","author":"Wilk","year":"2017","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0230","first-page":"227","article-title":"A preliminary investigation of the effect of relaxin on bone remodelling in suture expansion","volume":"39","author":"Duarte","year":"2017","journal-title":"Eur. J. Orthod."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4041\/kjod.2020.50.1.42","article-title":"The effect of cetirizine, a histamine 1 receptor antagonist, on bone remodeling after calvarial suture expansion","volume":"50","author":"Hwang","year":"2020","journal-title":"Korean J. Orthod."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2012.11.030","article-title":"Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats","volume":"53","author":"Hokugo","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2023.116677_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2015.10.005","article-title":"Targeted delivery to bone and mineral deposits using bisphosphonate ligands","volume":"99","author":"Cole","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bone.2023.116677_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bonr.2018.06.007","article-title":"Bisphosphonate conjugation for bone specific drug targeting","volume":"9","author":"Farrell","year":"2018","journal-title":"Bone Rep"},{"key":"10.1016\/j.bone.2023.116677_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119477","article-title":"Nanocomposites drug delivery systems for the healing of bone fractures","volume":"585","author":"Chen","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0260","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/ejo\/12.3.330","article-title":"The effect of duration and magnitude of tensile mechanical forces on sutural tissue in vivo","volume":"12","author":"Steenvoorden","year":"1990","journal-title":"Eur. J. Orthod."},{"key":"10.1016\/j.bone.2023.116677_bb0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bone.2023.116677_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00956","article-title":"Calvarial suture-derived stem cells and their contribution to cranial bone repair","volume":"8","author":"Doro","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2020.11.037","article-title":"Cranial suture regeneration mitigates skull and neurocognitive defects in craniosynostosis","volume":"184","author":"Yu","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.bone.2023.116677_bb0280","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41578-020-0204-2","article-title":"Materials design for bone-tissue engineering","volume":"5","author":"Koons","year":"2020","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.bone.2023.116677_bb0285","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1038\/ncomms10526","article-title":"Stem cells of the suture mesenchyme in craniofacial bone development, repair and regeneration","volume":"7","author":"Maruyama","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0290","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ncb3139","article-title":"The suture provides a niche for mesenchymal stem cells of craniofacial bones","volume":"17","author":"Zhao","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0295","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.stemcr.2017.03.002","article-title":"Postnatal calvarial skeletal stem cells expressing PRX1 reside exclusively in the calvarial sutures and are required for bone regeneration","volume":"8","author":"Wilk","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.bone.2023.116677_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.653579","article-title":"The intertwined evolution and development of sutures and cranial morphology","volume":"09","author":"White","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010051","article-title":"Progress on the application of bortezomib and bortezomib-based nanoformulations","volume":"12","author":"Liu","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bone.2023.116677_bb0310","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1158\/2326-6066.CIR-16-0102","article-title":"Bortezomib relieves immune tolerance in nasopharyngeal carcinoma via STAT1 suppression and indoleamine 2,3-dioxygenase downregulation","volume":"5","author":"Jiang","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.bone.2023.116677_bb0315","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/jpet.118.247924","article-title":"Network-based analysis of bortezomib pharmacodynamic heterogeneity in multiple myeloma cells","volume":"365","author":"Ramakrishnan","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"18","key":"10.1016\/j.bone.2023.116677_bb0320","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1182\/blood-2008-08-174300","article-title":"Bortezomib induces osteoblast differentiation via wnt-independent activation of beta-catenin\/TCF signaling","volume":"113","author":"Qiang","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bone.2023.116677_bb0325","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jbmr.2741","article-title":"The proteasome inhibitor bortezomib maintains osteocyte viability in multiple myeloma patients by reducing both apoptosis and autophagy: a new function for proteasome inhibitors","volume":"31","author":"Toscani","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2023.116677_bb0330","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ijc.27342","article-title":"Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy","volume":"131","author":"Terpos","year":"2012","journal-title":"Int. J. Cancer"}],"updated-by":[{"DOI":"10.1016\/j.bone.2023.116816","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:45:41Z","timestamp":1762659941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":66,"alternative-id":["S8756328223000091"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116677","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone-targeted bortezomib increases bone formation within Calvarial trans-sutural distraction osteogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116677"}}